analysis

Sai Parenterals Ltd.

NSE: SAIPARENT

BSE: 544742

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

556.10-14.6 (-2.56%)

17 Jul, 12:00 AM

Overview Analysis

Statements Technicals Forecast Peers Resources News

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBox^TMWhat is StyleBox?

Neutral

This stock could not be classified into any of the StyleBoxes and hence a neutral stance.

Detail >

QVM scoreWhat is QVM score?

15.8 / 100

The stock has low QVM score relative to other stocks in the market. Bearish.

Analyst ratingWhat is Analyst rating?

No active sell-side coverage. Recommendations not available.

Technical indicatorsSee all >

30 %

Sai Parenterals Ltd. on 1D timeframe is bullish for 7 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

	2026 Apr 30	2026 May 31	2026 Jun 30	2026 Jul 17
Multiples
P/E (TTM)	149.16	150.05	182.29	172.30
P/B (latest)	10.40	4.36	5.30	5.01
P/S (TTM)	13.22	5.62	6.82	6.45
CAPE (3Y)	-	152.45	185.20	175.05
CAPE (5Y)	-	-	-	-
P/E (1Y Forward)	-	-	-	-
P/S (1Y Forward)	-	-	-	-
Yields (%)
Book to Market	0.10	0.23	0.19	0.20
Earnings yield	0.67%	0.67%	0.55%	0.58%
Operating CF yield	1.55%	3.65%	3.00%	3.17%
FCFE yield	-	1.23%	1.01%	1.07%
FCFF yield	-	-9.09%	-7.42%	-7.87%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance

NIFTY50

NIFTYPHARMA

Add benchmark

Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary

	SAIPARENT	NIFTY50	NIFTYPHARMA

Start Period	02 Apr 2026	02 Apr 2026	02 Apr 2026
End Period	17 Jul 2026	17 Jul 2026	17 Jul 2026
Cumulative Return	36.95%	7.14%	17.59%
CAGR	208.12%	27.98%	78.59%
Volatility (ann.)	34.22%	14.67%	13.75%
Max Drawdown	-10.85%	-5.91%	-3.55%
RoMaD	19.18%	4.73%	22.11%
Sharpe	3.32	1.47	3.97
Sortino	7.57	2.39	7.43
Sortino/√2	5.35	1.69	5.25

Style Analysis

Learn more about stock scores

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

16.2 / 100

↓

Sai Parenterals Ltd. is overvalued relative to other stocks in the market

What is Value score?

Momentum score

18.3 / 100

↓

Sai Parenterals Ltd. has low momentum relative to other stocks in the market

What is Momentum score?

Quality score

64.5 / 100

–

Sai Parenterals Ltd. has moderate quality relative to other stocks in the market

What is Quality score?

QVM score

15.8 / 100

↓

Sai Parenterals Ltd. has low QVM score with respect to other stocks in the market

What is QVM score?

Scorecard

How to read Scorecard?

A comprehensive scorecard to compare Sai Parenterals Ltd. on all metrics with other stocks. Access both rank and scores.

	Value	Market (All Stocks in NSE)	Sector (Healthcare)	Industry Group (Pharmaceuticals & Biotechnology)	Industry (Pharmaceuticals)
Size and Listing
Days since Listing	106.00
Enterprise value	2,356 Cr
Issue Price	392.00
Listing Price	405.00
Market Cap	2,457 Cr
Liquidity
Avg daily turnover 1M	25 Cr
Avg daily volume 1M	4,02,426
Avg daily turnover 3M	18 Cr
Avg daily volume 3M	3,28,413
Bid Ask Spread	3.96%
Volume surge ratio	1.24
Ownership
DII Holding %	6.70%
QoQ change DII holding %	0.00%
FII Holding %	5.73%
QoQ change FII holding %	0.00%
QoQ change Gov holding %	0.00%
Promoter holding %	51.16%
QoQ change Promoter holding %	0.00%
Promoter pledged %	0.00%
Retail Holding %	25.49%
QoQ change Retail holding %	0.00%

Checklist

What is Checklist?

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans

Benjamin Graham's Value

Piotroski F-Score

Dreman contrarian value

Peter Lynch Growth/Value

O'Shaugnessy Value

Templeton Growth/Value

Warren Buffet’s Consistent Compounders

John Neff’s contrarian value

Richard Driehaus Momentum Strategy

O'Shaughnessy Tiny Titans

Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

20.0 / 100

Sai Parenterals Ltd. passes 1 out of 5 of this checklist's rules

Hits

Market Cap is greater than ₹500 crore

Misses

Market Cap is less than ₹1500 crore

PS TTM is less than 1

One Year Rel Return is greater than 0%

Stock is in top 25.0 percentile, sorted by Price Momentum score in descending order

Frequently Asked Questions

What is the PB ratio of Sai Parenterals Ltd.?

The Price-to-Book (PB) ratio of Sai Parenterals Ltd. is 5.01. It compares the stock's market price to its book value per share.

What is the EV/EBITDA of Sai Parenterals Ltd.?

The EV/EBITDA of Sai Parenterals Ltd. is 60.88. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.

What is the debt-to-equity ratio of Sai Parenterals Ltd.?

The debt-to-equity (D/E) ratio of Sai Parenterals Ltd. is 0.68. The interest coverage ratio stands at 1.18x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.

What is the promoter holding in Sai Parenterals Ltd.?

Promoters hold 51.16% of Sai Parenterals Ltd. shares as per the latest quarterly shareholding disclosure.

What is the operating profit margin of Sai Parenterals Ltd.?

The operating profit margin of Sai Parenterals Ltd. is 5.73%, reflecting how much profit the company earns from its core operations relative to revenue.

What is the net profit margin of Sai Parenterals Ltd.?

The net profit margin of Sai Parenterals Ltd. is 3.74%, indicating the percentage of revenue that remains as profit after all expenses.

What is the Sharpely score for Sai Parenterals Ltd.?

On Sharpely's proprietary scoring system, Sai Parenterals Ltd. has a Quality Score of 64.5/100, Value Score of 15.7/100 and Price Momentum Score of 17.4/100, with an overall QVM Score of 15.8/100. The quality rating is moderate, value is low and price momentum is low. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.